Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CETP | P11597 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25920928 | 0.93 | SMN1; SMN2 (0.33) | TSHRSMN1; SMN2CETP | |
| SCHEMBL27480653 | 0.72 | TSHR (0.31) | TSHRSMN1; SMN2 | |
| SCHEMBL25930972 | 0.70 | CETP (0.32) | CETP | |
| SCHEMBL25920922 | 0.70 | — | — | |
| SCHEMBL25930970 | 0.69 | — | — | |
| SCHEMBL25777861 | 0.69 | — | — | |
| SCHEMBL25920925 | 0.68 | SMN1; SMN2 (0.31) | TSHRSMN1; SMN2 | |
| SCHEMBL25920937 | 0.67 | — | — | |
| SCHEMBL10341798 | 0.66 | SMN1; SMN2 (0.34) | TSHRSMN1; SMN2 | |
| SCHEMBL4832455 | 0.66 | SMN1; SMN2 (0.31) | TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242562-A1 | Compound of Formula (I), a Semiconductor Material Comprising at Least One Compound of Formula (I), a Semiconductor Layer Comprising at Least One Compound of Formula (I) and an Electronic Device Comprising at Least One Compound of Formula (I) | NOVALED GMBH (DE) | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242562-A1 | Compound of Formula (I), a Semiconductor Material Comprising at Least One Compound of Formula (I), a Semiconductor Layer Comprising at Least One Compound of Formula (I) and an Electronic Device Comprising at Least One Compound of Formula (I) | AFF4, AFF1, AFF2 | TSHR 2675/4885SMN1; SMN2 1942/4885CETP 3753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.